홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
SMMT
#672
Summit Therapeutics Inc. Common Stock
16.590
0
+7.66%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+7.66%
월간 변동
+4.60%
6달 변화
-16.47%
년간 변동율
-16.47%
이전 종가
15.410
0
Open
16.590
0
Bid
Ask
Low
16.590
0
High
16.590
0
양
263
마켓
주식
헬스케어
SMMT
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
82.92 M
98.12 M
697.69 M
701.7 M
737.68 M
775.37 M
—
Valuation ratios
Enterprise value
323.31 M
192.16 M
3.14 B
1.78 B
13.06 B
13.34 B
58.1 B
Price to earnings ratio
-6.18
-2.8
-12.2
-2.67
-57.56
-12.15
-106.61
Price to sales ratio
379.96
137.16
1 371.18
—
—
21.44 K
299.49 K
Price to cash flow ratio
-6.79
-3.42
-23.25
-21.31
-90.23
-40.5
-253.14
Price to book ratio
4.11
2.98
7.63
21.06
32.98
19.85
53.73
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.51
0.78
0.12
3.03
0.51
1.44
3.09
Return on equity %
0.66
1.06
0.62
7.91
0.57
1.64
3.9
Return on invested capital %
831.34
1 235.4
172.33
1 492.71
3 507.86
-10.83 K
—
Gross margin %
100
100
100
—
—
100
400
Operating margin %
6 185.23
4 764.29
10.23 K
—
—
-179.31 K
382.99 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
6 127.56
4 897.84
11.17 K
—
—
176.98 K
-368.23 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.41
3.8
16.93
9.3
10.15
9.87
29.42
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.02
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0.49
0
—
—
Long term debt to total equity ratio
—
—
—
1.29
0
—
—
Per share metrics
Operating cash flow per share
0.69
0.79
0.22
0.12
0.2
0.43
0.43
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
0.96
0.78
1.8
0.3
0.57
0.95
2.17
Net current asset value per share
1.26
1.05
3.4
0.31
0.59
0.96
2.22
Tangible book value per share
0.95
0.77
0.65
0.12
0.54
0.88
1.95
Working capital per share
0.97
0.78
3.2
0.27
0.53
0.87
1.9
Book value per share
1.14
0.9
0.66
0.13
0.54
0.88
1.96
뉴스
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
H.C. 웨인라이트, 서밋 테라퓨틱스 목표가 하향… 이유는?
H.C. Wainwright cuts Summit Therapeutics stock price target on China trial timing uncertainty
SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus
서밋 테라퓨틱스, 파이프라인 확장으로 Citizens의 투자의견 재확인
Citizens reiterates Summit Therapeutics stock rating on pipeline expansion
Summit Therapeutics Inc. (SMMT) Q4 2025 Earnings Call Transcript
Summit Therapeutics Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SMMT) 2026-02-23
서밋 테라퓨틱스 2025년 4분기 실적 발표: 임상 성공 불구, EPS 389% 미달
Summit Q4 2025 slides: clinical wins offset by 389% EPS miss
Earnings call transcript: Summit Therapeutics Q4 2025 reports significant EPS miss
서밋 테라퓨틱스, 실적 부진에도 주가 하락